During the past decade, Washington University Infusion Center Pharmacy conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University Infusion Center Pharmacy" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Washington University Infusion Center Pharmacy" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Malignant Melanoma" (2 trials), "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC" (1 trials), "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials) and "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Washington University Infusion Center Pharmacy" in a lesser frequency.

Most popular intervention types in "Washington University Infusion Center Pharmacy" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (3 trials), "Binimetinib" (2 trials), "5-Fluorouracil" (1 trials), "Antibody Drug Conjugate Chemotherapeutic" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University Infusion Center Pharmacy" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Washington University Infusion Center Pharmacy". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Washington University Infusion Center Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University Infusion Center Pharmacy, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".